APO RESEARCH · REPORT
Pre-Sterilized Syringe
Pre-sterilized syringes are syringe devices processed and packaged to maintain a specified sterile condition before their intended use or downstream filling operation.
Product & engineering
Understand the product.
Pre-sterilized does not mean prefilled. Distinguish the empty-device sterilisation process from filling, container closure and finished-product validation.
What turns activity into demand
Device demand is defined by container or delivery function, connection, materials and validated manufacturing. Prefilling adds formulation compatibility and storage integrity to the device boundary.
The commercial boundary
Injection, enteral, oral and analytical devices have different interfaces and intended uses. Representative images establish neither sterility nor clinical suitability.
What establishes sterile condition beyond appearance?
Pre-sterilized does not mean prefilled. Distinguish the empty-device sterilisation process from filling, container closure and finished-product validation.
Selected research
Industry Research
Pre-Sterilized Syringe Industry Research Report 2026
Market perspective
The global Pre-Sterilized Syringe market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pre-Sterilized Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pre-Sterilized Syringe is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pre-Sterilized Syringe is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pre-Sterilized Syringe include BD, Gerresheimer, Nipro Corporation, Schott, Stevanato, Simtra (Baxter), Rovi CM, Terumo and Vetter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pre-Sterilized Syringe market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pre-Sterilized Syringe Market by Company
BD
Gerresheimer
Nipro Corporation
Schott
Stevanato
Simtra (Baxter)
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
J.O.Pharma
West Pharma
Weigao Group
Shandong Zibo Minkang
Shandong Pharmaceutical Glass
Ningbo Zhengli
Shandong Ujoin
Pre-Sterilized Syringe Segment by Type
Glass Type
Plastic Type
Pre-Sterilized Syringe Segment by Application
Vaccine
Antithrombotic Drugs
Bioengineered Drugs
Other (Beauty, etc.)
Pre-Sterilized Syringe Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-Sterilized Syringe market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pre-Sterilized Syringe and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-Sterilized Syringe.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pre-Sterilized Syringe manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pre-Sterilized Syringe by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pre-Sterilized Syringe in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glass Type
- Plastic Type
Applications
- Vaccine
- Antithrombotic Drugs
- Bioengineered Drugs
- Other (Beauty, etc.)
Companies covered
- BD
- Gerresheimer
- Nipro Corporation
- Schott
- Stevanato
- Simtra (Baxter)
- Rovi CM
- Terumo
- Vetter
- Catalent
- Taisei Kako
- J.O.Pharma
- West Pharma
- Weigao Group
- Shandong Zibo Minkang
- Shandong Pharmaceutical Glass
- Ningbo Zhengli
- Shandong Ujoin
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pre-Sterilized Syringe Market Size (2021-2032)
- 2.2.2 Global Pre-Sterilized Syringe Sales (2021-2032)
- 2.2.3 Global Pre-Sterilized Syringe Market Average Price (2021-2032)
- 2.3 Pre-Sterilized Syringe by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glass Type
- 2.3.3 Plastic Type
- 2.4 Pre-Sterilized Syringe by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Vaccine
- 2.4.3 Antithrombotic Drugs
- 2.4.4 Bioengineered Drugs
- 2.4.5 Other (Beauty, etc.)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pre-Sterilized Syringe Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pre-Sterilized Syringe Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Pre-Sterilized Syringe Revenue of Manufacturers (2021-2026)
- 3.4 Global Pre-Sterilized Syringe Average Price by Manufacturers (2021-2026)
- 3.5 Global Pre-Sterilized Syringe Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pre-Sterilized Syringe, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pre-Sterilized Syringe, Product Type & Application
- 3.8 Global Manufacturers of Pre-Sterilized Syringe, Established Date
- 3.9 Global Pre-Sterilized Syringe Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BD
- 4.1.1 BD Company Information
- 4.1.2 BD Business Overview
- 4.1.3 BD Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BD Pre-Sterilized Syringe Product Portfolio
- 4.1.5 BD Recent Developments
- 4.2 Gerresheimer
- 4.2.1 Gerresheimer Company Information
- 4.2.2 Gerresheimer Business Overview
- 4.2.3 Gerresheimer Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Gerresheimer Pre-Sterilized Syringe Product Portfolio
- 4.2.5 Gerresheimer Recent Developments
- 4.3 Nipro Corporation
- 4.3.1 Nipro Corporation Company Information
- 4.3.2 Nipro Corporation Business Overview
- 4.3.3 Nipro Corporation Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nipro Corporation Pre-Sterilized Syringe Product Portfolio
- 4.3.5 Nipro Corporation Recent Developments
- 4.4 Schott
- 4.4.1 Schott Company Information
- 4.4.2 Schott Business Overview
- 4.4.3 Schott Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Schott Pre-Sterilized Syringe Product Portfolio
- 4.4.5 Schott Recent Developments
- 4.5 Stevanato
- 4.5.1 Stevanato Company Information
- 4.5.2 Stevanato Business Overview
- 4.5.3 Stevanato Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Stevanato Pre-Sterilized Syringe Product Portfolio
- 4.5.5 Stevanato Recent Developments
- 4.6 Simtra (Baxter)
- 4.6.1 Simtra (Baxter) Company Information
- 4.6.2 Simtra (Baxter) Business Overview
- 4.6.3 Simtra (Baxter) Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Simtra (Baxter) Pre-Sterilized Syringe Product Portfolio
- 4.6.5 Simtra (Baxter) Recent Developments
- 4.7 Rovi CM
- 4.7.1 Rovi CM Company Information
- 4.7.2 Rovi CM Business Overview
- 4.7.3 Rovi CM Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Rovi CM Pre-Sterilized Syringe Product Portfolio
- 4.7.5 Rovi CM Recent Developments
- 4.8 Terumo
- 4.8.1 Terumo Company Information
- 4.8.2 Terumo Business Overview
- 4.8.3 Terumo Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Terumo Pre-Sterilized Syringe Product Portfolio
- 4.8.5 Terumo Recent Developments
- 4.9 Vetter
- 4.9.1 Vetter Company Information
- 4.9.2 Vetter Business Overview
- 4.9.3 Vetter Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Vetter Pre-Sterilized Syringe Product Portfolio
- 4.9.5 Vetter Recent Developments
- 4.10 Catalent
- 4.10.1 Catalent Company Information
- 4.10.2 Catalent Business Overview
- 4.10.3 Catalent Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Catalent Pre-Sterilized Syringe Product Portfolio
- 4.10.5 Catalent Recent Developments
- 4.11 Taisei Kako
- 4.11.1 Taisei Kako Company Information
- 4.11.2 Taisei Kako Business Overview
- 4.11.3 Taisei Kako Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Taisei Kako Pre-Sterilized Syringe Product Portfolio
- 4.11.5 Taisei Kako Recent Developments
- 4.12 J.O.Pharma
- 4.12.1 J.O.Pharma Company Information
- 4.12.2 J.O.Pharma Business Overview
- 4.12.3 J.O.Pharma Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 J.O.Pharma Pre-Sterilized Syringe Product Portfolio
- 4.12.5 J.O.Pharma Recent Developments
- 4.13 West Pharma
- 4.13.1 West Pharma Company Information
- 4.13.2 West Pharma Business Overview
- 4.13.3 West Pharma Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 West Pharma Pre-Sterilized Syringe Product Portfolio
- 4.13.5 West Pharma Recent Developments
- 4.14 Weigao Group
- 4.14.1 Weigao Group Company Information
- 4.14.2 Weigao Group Business Overview
- 4.14.3 Weigao Group Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Weigao Group Pre-Sterilized Syringe Product Portfolio
- 4.14.5 Weigao Group Recent Developments
- 4.15 Shandong Zibo Minkang
- 4.15.1 Shandong Zibo Minkang Company Information
- 4.15.2 Shandong Zibo Minkang Business Overview
- 4.15.3 Shandong Zibo Minkang Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Shandong Zibo Minkang Pre-Sterilized Syringe Product Portfolio
- 4.15.5 Shandong Zibo Minkang Recent Developments
- 4.16 Shandong Pharmaceutical Glass
- 4.16.1 Shandong Pharmaceutical Glass Company Information
- 4.16.2 Shandong Pharmaceutical Glass Business Overview
- 4.16.3 Shandong Pharmaceutical Glass Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Shandong Pharmaceutical Glass Pre-Sterilized Syringe Product Portfolio
- 4.16.5 Shandong Pharmaceutical Glass Recent Developments
- 4.17 Ningbo Zhengli
- 4.17.1 Ningbo Zhengli Company Information
- 4.17.2 Ningbo Zhengli Business Overview
- 4.17.3 Ningbo Zhengli Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Ningbo Zhengli Pre-Sterilized Syringe Product Portfolio
- 4.17.5 Ningbo Zhengli Recent Developments
- 4.18 Shandong Ujoin
- 4.18.1 Shandong Ujoin Company Information
- 4.18.2 Shandong Ujoin Business Overview
- 4.18.3 Shandong Ujoin Pre-Sterilized Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Shandong Ujoin Pre-Sterilized Syringe Product Portfolio
- 4.18.5 Shandong Ujoin Recent Developments
5 Global Pre-Sterilized Syringe Market Scenario by Region
- 5.1 Global Pre-Sterilized Syringe Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pre-Sterilized Syringe Sales by Region: 2021-2032
- 5.2.1 Global Pre-Sterilized Syringe Sales by Region: 2021-2026
- 5.2.2 Global Pre-Sterilized Syringe Sales by Region: 2027-2032
- 5.3 Global Pre-Sterilized Syringe Revenue by Region: 2021-2032
- 5.3.1 Global Pre-Sterilized Syringe Revenue by Region: 2021-2026
- 5.3.2 Global Pre-Sterilized Syringe Revenue by Region: 2027-2032
- 5.4 North America Pre-Sterilized Syringe Market Facts & Figures by Country
- 5.4.1 North America Pre-Sterilized Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pre-Sterilized Syringe Sales by Country (2021-2032)
- 5.4.3 North America Pre-Sterilized Syringe Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pre-Sterilized Syringe Market Facts & Figures by Country
- 5.5.1 Europe Pre-Sterilized Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pre-Sterilized Syringe Sales by Country (2021-2032)
- 5.5.3 Europe Pre-Sterilized Syringe Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pre-Sterilized Syringe Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pre-Sterilized Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pre-Sterilized Syringe Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pre-Sterilized Syringe Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pre-Sterilized Syringe Market Facts & Figures by Country
- 5.7.1 South America Pre-Sterilized Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pre-Sterilized Syringe Sales by Country (2021-2032)
- 5.7.3 South America Pre-Sterilized Syringe Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pre-Sterilized Syringe Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pre-Sterilized Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pre-Sterilized Syringe Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pre-Sterilized Syringe Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pre-Sterilized Syringe Sales by Type (2021-2032)
- 6.1.1 Global Pre-Sterilized Syringe Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Pre-Sterilized Syringe Sales Market Share by Type (2021-2032)
- 6.2 Global Pre-Sterilized Syringe Revenue by Type (2021-2032)
- 6.2.1 Global Pre-Sterilized Syringe Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pre-Sterilized Syringe Revenue Market Share by Type (2021-2032)
- 6.3 Global Pre-Sterilized Syringe Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pre-Sterilized Syringe Sales by Application (2021-2032)
- 7.1.1 Global Pre-Sterilized Syringe Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Pre-Sterilized Syringe Sales Market Share by Application (2021-2032)
- 7.2 Global Pre-Sterilized Syringe Revenue by Application (2021-2032)
- 7.2.1 Global Pre-Sterilized Syringe Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pre-Sterilized Syringe Revenue Market Share by Application (2021-2032)
- 7.3 Global Pre-Sterilized Syringe Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pre-Sterilized Syringe Value Chain Analysis
- 8.1.1 Pre-Sterilized Syringe Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pre-Sterilized Syringe Production Mode & Process
- 8.2 Pre-Sterilized Syringe Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pre-Sterilized Syringe Distributors
- 8.2.3 Pre-Sterilized Syringe Customers
9 Global Pre-Sterilized Syringe Analyzing Market Dynamics
- 9.1 Pre-Sterilized Syringe Industry Trends
- 9.2 Pre-Sterilized Syringe Industry Drivers
- 9.3 Pre-Sterilized Syringe Industry Opportunities and Challenges
- 9.4 Pre-Sterilized Syringe Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst